Consistent with the results of this cross-sectional study, a previous study of 287 breast cancer cases from the EPIC-Heidelberg cohort found no association between hormone receptor status, tumor stage, and serum 27-HC levels37. This evidence concerns the gene NR4A1 and breast cancer.